Customized products liability insurance for manufacturers and distributors of medical technology and life sciences products.
Products and completed operations coverage for clinical trial stage life sciences companies and companies with new products in development.
Coverage for economic injury tailored to the life sciences industry and covers the wide range of activities medical technology and pharmaceutical companies perform.
Products and programs offered by our parent company, ProAssurance, provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve
Customized products liability insurance for manufacturers and distributors of medical technology and life sciences products.
Products and completed operations coverage for clinical trial stage life sciences companies and companies with new products in development.
Coverage for economic injury tailored to the life sciences industry and covers the wide range of activities medical technology and pharmaceutical companies perform.
Products and programs offered by our parent company, ProAssurance, provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve
Customized products liability insurance for manufacturers and distributors of medical technology and life sciences products.
Products and completed operations coverage for clinical trial stage life sciences companies and companies with new products in development.
Coverage for economic injury tailored to the life sciences industry and covers the wide range of activities medical technology and pharmaceutical companies perform.
Products and programs offered by our parent company, ProAssurance, provide a single source of innovative healthcare liability insurance solutions to the life sciences companies we serve
February 3, 2021
A look at potential changes facing FDA-regulated life sciences industry in 2021. Presented by James Boiani of Epstein Becker and Green.
Previously Recorded on December 16, 2020
In this year’s annual year-end wrap-up, a panel that includes members of Medmarc’s Claims team along with David Waxman of Saul Ewing Arnstein & Lehr LLP will summarize the state of the medical device industry for “2020: A Year Unlike Any Other.” The panel will include discussions on areas involving...
Previously Recorded on December 2, 2020
In this installment of Medmarc’s webinar series, Kate Klaus, an attorney and FDA specialist in our Risk Management department, will guide a discussion of the top life sciences news stories of the past year and their potential implications for products liability. Topics will include: The dramatic im...
Previously Recorded on October 28, 2020
The medtech industry has significantly changed during the Trump administration’s last four years. FDA processes are streamlined, the medical device excise tax repealed, and the Senate is in the process of confirming a third Supreme Court nominee The industry also rapidly responded to the unprecedent...
Previously Recorded on September 1, 2020
In this session, presenter, Joy McElroy from McElroy Training and Consultancy, will discuss the benefits of good technical writing, how to write effective and compliant SOPs using the correct person, correct voice and formatting effective SOPs. Participants can expect to learn: The correct SOP comp...